Tucows (TCX) Q4 2025 (Q&A) earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 (Q&A) earnings summary
25 Feb, 2026Executive summary
Addressed investor questions on Ting asset sale, Wavelo EBITDA margin outlook, and stock buyback program.
Achieved third consecutive year of growth in consolidated revenue, gross profit, and adjusted EBITDA for FY 2025, with adjusted EBITDA up 45% year-over-year.
Fiscal 2025 saw revenue rise 8% year-over-year, with all business units contributing to growth.
Core businesses, Domains and Wavelo, demonstrated strong recurring revenue and margin profiles.
Strategic process to divest Ting is underway to improve capital flexibility and focus on core segments.
Financial highlights
Q4 2025 net revenues were $98.7M, up 6% year-over-year; full-year revenues reached $390.3M, up 8%.
Q4 gross profit was $24.1M, up 14% year-over-year; full-year gross profit was $94.0M, up 13%.
Q4 net loss improved to $(22.0)M from $(42.5)M; full-year net loss improved to $(75.8)M from $(109.9)M.
Adjusted EBITDA for Q4 was $11.1M, down 14% year-over-year; full-year adjusted EBITDA was $50.6M, up 45%.
Net cash used in operating activities for the year was $5.8M, a 71% improvement year-over-year.
Outlook and guidance
Wavelo's adjusted EBITDA margin is expected to decline year-over-year in 2026 due to potential fee reductions from Ting process outcomes and fully annualized investments.
Conservative forecasting for Wavelo reflects a range of possible Ting divestiture outcomes.
Management remains focused on operational and capital efficiency, with ongoing strategic processes in Ting to build a more resilient earnings profile.
Focus on scaling Domains and Wavelo, leveraging recurring revenue and margin strength.
Divestiture of Ting expected to enhance capital allocation for self-funded growth and deleveraging.
Latest events from Tucows
- Q4 2025 revenue up 6%, gross profit up 14%, and adjusted EBITDA up 45% year-over-year.TCX
Q4 2025 Prepared Remarks13 Feb 2026 - Q2 2024 revenue up 5% to $89.4M, gross profit and EBITDA surged, net loss narrowed.TCX
Q2 2024 Prepared Remarks1 Feb 2026 - Q2 2024 revenue up 5%, EBITDA up 70%, net loss narrows, and $63M ABS secured.TCX
Q2 2024 (Q&A)23 Jan 2026 - Q3 2024 revenue up 6.1%, adjusted EBITDA nearly doubled, but risks and cost cuts persist.TCX
Q3 2024 Prepared Remarks15 Jan 2026 - Q3 2024 revenue up 6%, gross profit up 32%, with cost controls and liquidity risks persisting.TCX
Q3 2024 (Q&A)12 Jan 2026 - Q2 2025 saw 10% revenue growth, margin expansion, and key registry contracts secured.TCX
Q2 2025 (Q&A)6 Jan 2026 - Facing regulatory and financial headwinds, the company seeks up to $500M for new initiatives.TCX
Registration Filing17 Dec 2025 - Q4 2024 saw 7.1% revenue growth, 403% adjusted EBITDA rise, and strong Ting performance.TCX
Q4 2024 (Q&A)16 Dec 2025 - Q4 revenue and EBITDA surged, with 2025 guidance targeting a 75% EBITDA increase.TCX
Q4 2024 Prepared Remarks2 Dec 2025